Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.
Journal: British Journal Of Haematology
Published:
Authors
George Somlo, Ashkan Lashkari, William Bellamy, Todd Zimmerman, Joseph Tuscano, Margaret O'donnell, Ann Mohrbacher, Stephen Forman, Paul Frankel, Helen Chen, James Doroshow, David Gandara
Relevant Conditions